Moreoverwe detected the pattern recognition receptor CD14which is expressed by both monocytes and neutrophils and has been proposed as potential target to reduce acute inflammation in COVID-19 patients [32] together with LBP (LPS binding protein) a protein responsible for the potentiation of LPS-mediated activation of monocytes/neutrophils via CD14 [33]. The gene discussed is CD14; the disease is COVID-19.